Home › NASDAQ: NRBO
News Price History Option Chain Financials Insider Trading Why NRBO Down? Discussions Forecast Stock Split Dividend History
Neurobo Pharmaceuticals Stock (NRBO) Financials Data
Debt to Equity Ratio
About Neurobo Pharmaceuticals
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company that develops and commercializes multimodal disease-modifying therapies for viral, neuropathic, and neurodegenerative diseases. It develops ANA001, a proprietary oral niclosamide formulation for the treatment of patients with moderate COVID-19; NB-01 for the treatment of painful diabetic neuropathy; NB-02 to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases associated with the malfunction of tau protein; and Gemcabene for various indications, including COVID-19 in combination with ANA001. NeuroBo Pharmaceuticals, Inc. is headquartered in Boston, Massachusetts.
Cap: | Volume (24h):